Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61)

This grant solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic, clinical, or epidemiological cancer research. The emphasis of this FOA is on supporting the development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology. 

Funding: $500,000 per year 

Duration: 3 years

Research Authority due date: 10 days prior to submission 

LOI (encouraged) due date: 1.2.23, 1.8.23

Full proposal due date: 1.3.23, 1.9.23